Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo

Blood

Volumn 99, Issue 1, 2002, Pages 185-192

  Dobrina, Aldo ^b   Pausa, Mario ^b   Fischetti, Fabio ^b   Bulla, Roberta ^b   Vecile, Elena ^b   Ferrero, Elisabetta ^b   Mantovani, Alberto ^b   Tedesco, Francesco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C5A; INACTIVE TERMINAL COMPLEMENT COMPLEX; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CYTOLYSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MICROSCOPY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENULE;

EID: 0036092972     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.185     Document Type: Article

References (51)

1. Complement membrane attack on nucleated cells: Resistance, recovery and nonlethal effects
2. Membrane signalling by complement C5b-9, the membrane attack complex
3. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface
4. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1
5. The membrane attack complex of complement induced interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells
6. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells
7. Complement-mediated regulation of tissue factor activity in endothelium
8. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex
9. Transient perturbation of endothelial integrity induced by natural antibodies and complement
10. Complement complex C5b-8 induces PG12 formation in cultured endothelial cells
11. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model: Role of cyclooxygenase-2
12. The C5b-9 complex: Formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum
13. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis
14. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: Neutralization of a C5b-9 inhibitor by anti-body to CD59
15. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus
16. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity
17. Regulation of complement protein gene expression
18. Mononuclear phagocytes have the potential to synthesize the complete functional complement system
19. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system of primary syndrome or systemic lupus erythematosus
20. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis
21. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system
22. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a (desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope
23. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis
24. A versatile video image analysis system for microcirculatory research
25. Leukocyte adherence to venular endothelium during ischemia-reperfusion
26. Endothelial cell E- and P-selectin and vascular cell adhesion molecole-1 function as signaling receptor
27. CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes
28. Chemotactic agonists induce cytokine generation in eosinophils
29. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer
30. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
31. Characterization of complement anaphylatoxins and their biological responses
32. A comparison of C3a- and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo
33. C5a-induced expression of P-selectin in endothelial cell
34. Chemotactic response to human C3a and C5a anaphylatoxins, I: Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions
35. Role of resident macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10
36. The chemotactic activity for neutrophil and eosinophil leukocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the "reactive lysis" procedure
37. Hemolytically inactive C5b67 complex: An agonist of polymorphonuclear leukocytes
38. In vitro and in vivo response of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67)
39. Cooperative interactions of LFA-1 and MAC-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro
40. Inlerleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage
41. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-α
42. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration
43. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1
44. Regulation of transendothelial neutrophil migration by endogenous interleukin-8
45. Neutrophil migration across monolayer of cytokine-prestimulated endothelial cells: A role for platelet-activating factor and IL-8
46. IFN-γ TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells
47. Tumor necrosis factor α-induced vascular leakage involve PECAM1 phosphorylation
48. The biology of PECAM-1
49. PECAM-1 is required for transendothelial migration of leukocytes
50. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo
51. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane